Atlas Trials

Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies

Clinical trial NCT00024648 · COMPLETED

Trial details

NCT number
NCT00024648
Sponsor
INSYS Therapeutics Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2001-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.